SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending with community chatter focusing on the stock's recent upward momentum, driven by speculation around potential catalysts and technical factors. Some traders point to a possible gamma squeeze and overall market strength, while others express skepticism, citing valuation concerns and mixed fundamentals. The discussion includes debate on whether the rally is sustainable or if a pullback is imminent.

Gemini Space Station Inc. - Ordinary Shares- Class A

Gemini Space Station

Gemini Space Station's IPO is trending amid volatile price action, sparking debates about IPO allocations and the influence of retail investors. The community is weighing the long-term potential against concerns over reported losses and the overall crypto market sentiment, while also comparing it to other recent IPOs. Some traders express excitement about potential gains, while others are wary of the stock's high valuation and the involvement of the Winklevoss twins.

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.

Atyr Pharma Inc

aTyr Pharma, Inc

Anticipation is building around aTyr Pharma as it approaches the topline Phase 3 data release for efzofitimod in pulmonary sarcoidosis, driving significant community discussion. While some traders are eyeing a potential pump and dump scenario, others are optimistic about the trial's outcome and future indications, highlighting strong institutional ownership and potential for a short squeeze. The community is closely monitoring for any data leaks and debating the influence of prominent figures on the stock's movement.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending as the community discusses potential partnerships and integrations, particularly within the Solana ecosystem. Bullish sentiment is fueled by discussions around real-world asset (RWA) adoption and the anticipation of increased volume as more markets open.

Sonnet BioTherapeutics Holdings, Inc. is a clinical stage biotechnology company, which engages in the innovation of biologic medicines. Its Fully Human Albumin Binding (FHAB) technology utilizes a single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its pipeline focuses on cytokines, a class of cell signaling peptides that, among other important functions, serve as potent immunomodulatory agents. The company was founded by Pankaj Mohan and John K. Cini in 2011 and is headquartered in Princeton, NJ.

Sonnet BioTherapeutics Holdings Inc

SONN is trending due to speculation surrounding a potential merger related to cryptocurrency, with community members pointing to a possible short squeeze given the stock's high short interest. Conversations revolve around predictions of a significant price increase and the potential impact of the merger on shareholder value. Some traders are actively shorting the stock, anticipating a price crash, while others remain bullish, drawing comparisons to similar stocks that have experienced substantial gains.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer ($PFE) is trending due to reports suggesting the Trump administration may link COVID-19 vaccines to child deaths, sparking concerns about potential liabilities and renewed scrutiny of vaccine safety data. The community is debating the validity of the reports and the potential impact on vaccine manufacturers, while some investors see the dip as a buying opportunity for the high-dividend stock.  Others believe Pfizer is more than just a vaccine company and should be evaluated as a cancer treatment company.

Asset Entities, Inc. engages in providing social media marketing and content delivery services. It offers its services to Discord, TikTok, and other social media platforms. It also designs, develops and manages servers for communities on Discord. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani and Kyle Fairbanks on August 1, 2020 and is headquartered in Dallas, TX.

Asset Entities Inc - Ordinary Shares - Class B

Asset Entities Inc.

Asset Entities Inc. is trending as traders anticipate the closing of its merger with Strive, potentially transforming it into a Bitcoin treasury company; high short interest and borrow fees add to the excitement, with the community debating the impact of potential dilution and the timing of news releases, as well as the possibility of a short squeeze. Despite some volatility, many investors express confidence in the long-term potential, urging others to hold firm.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FCEL is trending due to recent earnings and increased discussion around its potential in AI data center power, with community members highlighting its fast “contract-to-power” deployment. Some are expressing optimism for a continued rally, while others are debating the company's path to profitability and comparing it to sector peers like BE and PLUG. Discussion also includes potential catalysts such as new deals, partnerships, and broader adoption of clean energy initiatives.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

Cleanspark is trending as investors discuss its potential pivot to AI/HPC alongside Bitcoin mining, with some expressing frustration over its recent performance compared to other miners like CIFR and IREN. Community members are debating whether the company is undervalued, citing its Bitcoin treasury and potential for growth in the AI sector, while also scrutinizing executive compensation and short selling activity.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IONQ is trending due to regulatory clearance for its acquisition of Oxford Ionics, sparking discussions about the company's future and potential catalysts such as the upcoming Quantum World Congress. Community perspectives are mixed, with some highlighting the acquisition's significance while others express concerns about revenue and valuation. The stock is also being compared to NVDA, with some seeing it as the next big thing in computing.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Analysts Think Chewy (CHWY) Is a Good Investment: Is It?

The average brokerage recommendation (ABR) for Chewy (CHWY) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Chewy Q2 Earnings Beat Estimates, FY25 Sales Outlook Raised

CHWY posts strong second-quarter results with rising Autoship sales and higher margins. It raises the full-year sales outlook.

JPMorgan on Wednesday maintained its 'Overweight' rating on Chewy stock, calling the over 16% drop following the company's quarterly results an overreaction, according to the summary of the investor note on The Fly.Chewy reported second-quarter revenue above expectations and adjusted earnings per share (EPS) in line with targets. The company boosted its full-year sales forecast to a $12.5 billion to $12.6 billion range, up from $12.3 billion to $12.45 billion.However, a 79% fall in quarterly net profit and less-than-expected investment into the business&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/chewy-stock-sinks-15-as-q2-net-income-falls/chwkSi4RduH">raised concerns</a>, causing the shares to fall.JP Morgan, which trimmed its price target on the company's shares by $2 to $45, noted that investors are likely worried about margin compression in the second half of the year.The slide also follows recent momentum in the stock. Before Wednesday's session, CHWY shares had gained nearly 23% since a recent low in August, and 27% year-to-date.Currently, 18 of the 28 analysts covering the stock rate it 'buy' or higher, and nine rate it 'hold,' according to Koyfin data. Their average price target is $45.6, implying a 30% upside from the last close.Stocktwits users noted the drop to be a buying opportunity, with retail sentiment climbing higher in the 'extremely bullish' zone.<stembedurl>https://stocktwits.com/JOEYBUYDEN/message/628242827</stembedurl>Analysts have previously raised concerns about the company’s<a href="https://stocktwits.com/news-articles/markets/equity/chewy-analyst-steps-to-sidelines-on-valuation-concerns-retail-agrees/chkzXthRbx0">&nbsp;high valuation</a> (Chewy stock hit a two-and-a-half-year high in June).&nbsp;Still,&nbsp;its financials have improved in recent quarters, driven by wider adoption of its Autoship subscription program,&nbsp;which lets customers schedule deliveries and gain priority access to popular products and essentials.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/ai-upstart-perplexity-hits-whopping-20b-valuation-with-new-200m-raise-report/chwNEBCRdHQ">AI Upstart Perplexity Hits Whopping $20B Valuation With New $200M Raise: Report</a>

A woman opening online parcels with her dog. (Photo: Edwin Tan via Getty Images)

Chewy Retail Watchers Sniff Buying Opportunity After 16% Plunge Post Earnings — Analyst Calls Selloff Overblown

Investment advisory firms JP Morgan and Mizuho maintained their 'buy' calls post the pet product retailer's second quarter report.

Equity

Investment advisory firms JP Morgan and Mizuho maintained their 'buy' calls post the pet product retailer's second quarter report.


Chewy Inc (CHWY) shares tumbled 15% during midday trading on Wednesday after the company posted a fall in second-quarter (Q2) net income due to higher operating expenses.The company’s quarterly net income fell to $62 million, compared to $299.1 million a year ago. Operating expenses in the quarter rose 7.5% to $872.5 million.Retail sentiment on <a href="https://stocktwits.com/symbol/CHWY">Chewy</a> remained unchanged in the ‘extremely bullish’ territory, with chatter at ‘extremely high’ levels, according to data from Stocktwits.<figure class="image"><img style="aspect-ratio:807/105;" src="https://news.stocktwits-cdn.com/CHWY_sentiment_png_09dd7d62a3.webp" alt="CHWY sentiment.png" width="807" height="105"><figcaption>CHWY sentiment and message volume September 10, 2025, as of 12 pm ET | Source: Stocktwits</figcaption></figure>Analysts at Mizuho noted that Chewy shares are down meaningfully on "another OpEx miss" and incremental investments planned for the second half, according to TheFly.The firm said that even though it acknowledges that re-investing upside is "disappointing," it thinks this could expedite revenue upside and believes shares being off by more than 15% "seems like too much."Mizuho also added that Q2 results came in slightly ahead of expectations. The firm maintained its ‘Outperform’ rating and $50 price target on Chewy.Chewy’s Q2 revenue came in at $3.10 billion, edging past Wall Street expectations of $3.08 billion, according to data compiled by Fiscal AI. Its adjusted earnings per share (EPS) of $0.33 came in line with analysts’ estimates.Separately, the company also announced the launch of “Get Real,” a new line of minimally processed, fresh dog food available only at Chewy as part of its efforts to build on the growing demand for pet food.Shares of Chewy have gained 4% this year and have jumped over 15% in the last 12 months.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-wlds-stock-skyrocket-850-today/chwkKHrRdus">Why Did WLDS Stock Skyrocket 850% Today?</a>

Chewy stock had made headlines recently after Keith Gill a.k.a ‘Roaring Kitty’ disclosed a stake in the firm.

Chewy Stock Sinks 15% As Q2 Net Income Falls: Here's What This Analyst Has To Say

Analysts at Mizuho noted that Chewy shares are down meaningfully on "another OpEx miss" and incremental investments planned for the second half.

Chewy (CHWY) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for Chewy (CHWY) give a sense of how the business performed in the quarter ended July 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Chewy (CHWY) Meets Q2 Earnings Estimates

Chewy (CHWY) delivered earnings and revenue surprises of 0.00% and +0.71%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?

Chewy (CHWY) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Beyond analysts' top-and-bottom-line estimates for Chewy (CHWY), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended July 2025.

Chewy (CHWY) Suffers a Larger Drop Than the General Market: Key Insights

Chewy (CHWY) concluded the recent trading session at $39.44, signifying a -3.71% move from its prior day's close.

Chewy (CHWY) Is Considered a Good Investment by Brokers: Is That True?

According to the average brokerage recommendation (ABR), one should invest in Chewy (CHWY). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Why Chewy (CHWY) Outpaced the Stock Market Today

The latest trading day saw Chewy (CHWY) settling at $40.75, representing a +2.53% change from its previous close.

Chewy, Inc. operates as an online retailer of pet food and other pet-related products and services. It supplies pet medications, food, treats and other pet-health products and services for dogs, cats, fish, birds, small pets, horses, and reptiles. It has a portfolio of pet healthcare offerings that includes Chewy Pharmacy, Connect with a Vet, and CarePlus, an exclusive suite of pet-first insurance and wellness plans. The company was founded by Ryan Cohen and Michael Day in September 2011 and is headquartered in Plantation, FL.

CHWY
Chewy Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest CHWY News

CHWY Chewy Inc